|
Symbol
|
RMA9EV | ABKBTQ | RMADDV | RMAVPV | Z0AYWZ | RMAEBV | RMBYGV | RMAO0V | RMBNFV | Z0B8PZ | QRERCH | RMAJVV | QTHRCH | RMATAV | ADPWTQ | QVMRCH | RMA5LV | Z25BGZ | RMAMRV | RMAQPV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Auto-Callable Multi Defender VONTI | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Douglas Hldg. AG / Galderma Group AG / UNILEVER TMICC BASKET | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Compagnie Financière Richemont SA / Galderma Group AG / L'Oréal S.A. / LVMH Moet Hennessy Louis Vuitton | Accelleron Industries AG / Galderma Group AG / Givaudan | Alcon / Galderma Group AG / Novartis AG / Roche PS / Sandoz Group AG | Galderma Group AG / Nestlé S.A. / Novartis AG | Alcon / Galderma Group AG / Straumann Hldg. AG | Alcon / Galderma Group AG / Roche PS / Sandoz Group AG | Galderma Group AG / Roche PS / Sanofi S.A. | Alcon / Bachem Hldg. AG / Galderma Group AG | Galderma Group AG / Roche PS / Sandoz Group AG | Galderma Group AG / Partners Group Hldg. AG / Swiss Life Hldg. N | Galderma Group AG / Nestlé S.A. / Novartis AG / Roche PS / Straumann Hldg. AG | Adecco Group AG / Galderma Group AG / UBS Group AG | Alcon / Galderma Group AG / Lonza Group N | Galderma Group AG / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Alcon / Galderma Group AG / Novartis AG / Roche PS / Straumann Hldg. AG | Bachem Hldg. AG / Galderma Group AG / Novartis AG / Sandoz Group AG | Galderma Group AG / Lonza Group N / Straumann Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
28.09.2026 | 12.11.2026 | 05.01.2027 | 22.03.2027 | 08.07.2027 | 25.05.2027 | 10.12.2026 | 21.12.2026 | 05.07.2027 | 05.07.2027 | 07.01.2027 | 18.01.2027 | 18.01.2027 | 23.07.2027 | 29.10.2026 | 11.11.2026 | 23.08.2027 | 01.03.2027 | 30.11.2026 | 12.03.2027 |
| Demande | - | 98,91 | 100,60 | 84,20 | - | 92,10 | 100,80 | 99,20 | 97,00 | - | 101,41 | 100,50 | 84,72 | 99,70 | 93,81 | 100,24 | 97,00 | - | 100,10 | 99,10 |
| Offre | - | 99,71 | 101,60 | - | - | 93,10 | 101,80 | 100,20 | 98,00 | - | 102,22 | 101,50 | 85,52 | 100,70 | - | - | 98,40 | - | 101,10 | 100,10 |